Phospho-IKBKG (Ser376) Antibody

What is IKBKG and why is phosphorylation at Ser376 significant?

IKBKG, also known as NF-κB essential modulator (NEMO), is the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex that activates NF-κB, leading to activation of genes involved in inflammation, immunity, cell survival, and other pathways . Phosphorylation at Ser376 represents a critical post-translational modification that regulates IKBKG function within the NF-κB signaling pathway. This specific phosphorylation event is particularly important because it influences the protein's ability to mediate downstream signaling events, including ERK phosphorylation and NF-κB p65 nuclear translocation, which are essential for proper immune function .

How does phosphorylated IKBKG (Ser376) differ functionally from non-phosphorylated IKBKG?

Phosphorylation at Ser376 modifies IKBKG's functional capabilities within the NF-κB signaling pathway. While non-phosphorylated IKBKG participates in the formation of the IKK complex, phosphorylation at Ser376 appears to be particularly important for specific downstream events beyond IκBα degradation. Research has demonstrated that even when IκBα degradation remains intact, deficiencies in IKBKG phosphorylation can severely impair ERK phosphorylation and nuclear translocation of p65 . This indicates that phosphorylation at this site plays a role in regulating specific branches of NF-κB signaling rather than globally affecting all IKBKG functions.

What is the relationship between IKBKG phosphorylation at Ser376 and other post-translational modifications?

IKBKG undergoes multiple post-translational modifications that collectively regulate its function. Beyond phosphorylation at Ser376, IKBKG can be phosphorylated at Ser68, which attenuates aminoterminal homodimerization . It also undergoes several ubiquitination events: polyubiquitination on Lys-285 via 'Lys-63'-linked ubiquitin (mediated downstream of NOD2 and RIPK2), polyubiquitination on Lys-285 and Lys-399 (mediated by BCL10, MALT1, and TRAF6), and monoubiquitination on Lys-277 and Lys-309 (which promotes nuclear export) . These modifications work in concert to regulate IKBKG's scaffolding function, with phosphorylation at Ser376 potentially influencing or being influenced by these other modifications in the coordination of immune signaling.

What are the key characteristics of Phospho-IKBKG (Ser376) antibodies?

Phospho-IKBKG (Ser376) antibodies are specifically designed to detect IKBKG protein only when phosphorylated at Serine 376 . They are available in multiple formats, including rabbit polyclonal antibodies that target the region around the Ser376 phosphorylation site (typically within amino acids 342-391 or 320-400) . These antibodies are highly specific and do not cross-react with non-phosphorylated IKBKG. They are typically supplied at a concentration of 1 mg/mL in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide . Additionally, some suppliers offer PE-conjugated mouse monoclonal antibodies (clone N19-39) against human IKKγ (pS376) for flow cytometry applications .

How do I select the appropriate Phospho-IKBKG (Ser376) antibody for my specific research application?

Selecting the appropriate antibody requires consideration of multiple factors:

• Application compatibility: Verify that the antibody has been validated for your intended application (IHC, IF, ELISA, WB, or flow cytometry) .

• Species reactivity: Confirm that the antibody recognizes your species of interest (human, mouse, rat) .

• Clonality needs: Polyclonal antibodies offer broader epitope recognition, while monoclonal antibodies provide higher specificity and reproducibility.

• Conjugation requirements: For direct detection methods like flow cytometry, consider pre-conjugated antibodies (e.g., PE-conjugated) .

• Validation data: Examine available data demonstrating specificity and sensitivity for phospho-Ser376 IKBKG.

For Western blotting applications, rabbit polyclonal antibodies with documented sensitivity for endogenous protein levels are recommended . For flow cytometry, PE-conjugated mouse monoclonal antibodies provide optimal results .

What are the recommended protocols for detecting phosphorylated IKBKG (Ser376) in different experimental setups?

For Western Blotting (1:1000 dilution) :

• Lyse cells in buffer containing phosphatase inhibitors to preserve phosphorylation status

• Separate proteins by SDS-PAGE and transfer to membrane

• Block with appropriate blocking buffer (typically 5% BSA)

• Incubate with Phospho-IKBKG (Ser376) antibody overnight at 4°C

• Wash and incubate with HRP-conjugated secondary antibody

• Develop using chemiluminescence detection

• Expected molecular weight: approximately 50 kDa

For Immunohistochemistry (1:100-1:300 dilution) :

• Deparaffinize and rehydrate tissue sections

• Perform antigen retrieval (details should be optimized based on tissue type)

• Block endogenous peroxidase and non-specific binding

• Incubate with Phospho-IKBKG (Ser376) antibody at 4°C overnight

• Apply appropriate detection system (e.g., HRP-polymer and DAB)

• Counterstain, dehydrate, and mount

For Immunofluorescence (1:50-1:200 dilution) :

• Fix cells with 4% paraformaldehyde and permeabilize with 0.1-0.3% Triton X-100

• Block with appropriate blocking solution

• Incubate with Phospho-IKBKG (Ser376) antibody at 4°C overnight

• Wash and incubate with fluorophore-conjugated secondary antibody

• Counterstain nuclei with DAPI and mount with anti-fade mounting medium

How can I effectively study IKBKG phosphorylation in the context of TLR signaling?

To study IKBKG phosphorylation in TLR signaling:

• Stimulation protocol: Treat cells with specific TLR ligands such as LPS (TLR4), MALP-2 (TLR2/6), Pam3CSK4 (TLR1/2), poly(I:C) (TLR3), R-848 (TLR7/8), or CpG ODN (TLR9) .

• Time course: Collect samples at multiple time points (0-120 minutes) to capture transient phosphorylation events.

• Controls: Include positive controls (IFN-γ pre-activated cells) and negative controls (cells from TLR-deficient models) .

• Detection methods: Use Western blotting with Phospho-IKBKG (Ser376) antibody to detect phosphorylation status, alongside antibodies against phospho-ERK, phospho-p38, phospho-IκBα, and total proteins.

• Functional readouts: Measure downstream events such as cytokine production, NO synthesis, and NF-κB p65 nuclear translocation .

• Subcellular fractionation: Separate nuclear and cytoplasmic fractions to assess p65 translocation as influenced by IKBKG phosphorylation .

This approach allows for comprehensive analysis of how IKBKG phosphorylation at Ser376 contributes to specific branches of TLR signaling pathways.

What are the best methods for assessing the functional consequences of IKBKG phosphorylation at Ser376?

To assess functional consequences of IKBKG Ser376 phosphorylation:

• Phosphomimetic and phosphodeficient mutants: Generate S376D (phosphomimetic) and S376A (phosphodeficient) IKBKG mutants for expression in IKBKG-deficient cells.

• Signaling pathway analysis: Monitor multiple branches of NF-κB signaling, including:

  • IκBα degradation kinetics

  • p38 MAPK phosphorylation

  • ERK and MEK phosphorylation

  • p65 nuclear translocation

• Protein interaction studies: Perform co-immunoprecipitation to identify phosphorylation-dependent protein interactions.

• Cellular responses: Measure:

  • Cytokine production (TNF-α, IL-6, IL-1β)

  • NO synthesis (particularly in IFN-γ pre-activated macrophages)

  • Cell viability using MTT assays

• In vivo models: If available, analyze phenotypes of knock-in mice expressing phospho-deficient IKBKG (S376A) compared to wild-type, assessing:

  • Lymph node development

  • Memory T cell differentiation

  • Regulatory T cell populations

  • Susceptibility to infection

How can I optimize detection of phosphorylated IKBKG (Ser376) in Western blot experiments?

To optimize detection of phosphorylated IKBKG (Ser376):

• Sample preparation:

  • Use phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) in lysis buffers

  • Lyse cells directly in hot 2X SDS sample buffer for immediate denaturation to preserve phosphorylation

  • Process samples rapidly at cold temperatures

• Blocking optimization:

  • Use 5% BSA instead of milk (milk contains phosphatases)

  • Consider specialized blocking buffers designed for phosphoprotein detection

• Antibody conditions:

  • Optimize primary antibody dilution (starting with 1:1000)

  • Extend primary antibody incubation to overnight at 4°C

  • Use TBS-T instead of PBS-T for wash buffers (phosphate in PBS can interfere)

• Signal enhancement:

  • Try signal enhancers specific for phosphoprotein detection

  • Consider using highly sensitive ECL substrates

  • For weak signals, consider amplification systems

• Positive controls:

  • Include samples from cells treated with known activators of IKBKG phosphorylation

  • Use phosphatase-treated negative controls to confirm specificity

What are the common pitfalls when working with Phospho-IKBKG (Ser376) antibodies, and how can they be addressed?

Common pitfalls and their solutions include:

• Loss of phosphorylation signal:

  • Ensure rapid processing of samples

  • Use fresh phosphatase inhibitors in all buffers

  • Avoid repeated freeze-thaw cycles of lysates

• High background:

  • Increase washing steps and duration

  • Optimize antibody dilution (try higher dilutions)

  • For IHC/IF, include a peroxidase/phosphatase quenching step

  • Use more stringent blocking conditions

• Cross-reactivity issues:

  • Validate antibody specificity using phosphatase-treated controls

  • Include IKBKG-deficient samples as negative controls

  • Use blocking peptides specific to the phospho-epitope

• Inconsistent results between experiments:

  • Standardize stimulation conditions and timing

  • Use consistent cell densities

  • Prepare fresh working dilutions of antibody for each experiment

  • Consider using loading controls specific for phosphorylated proteins

• Difficulty detecting endogenous levels:

  • Enrich for the protein of interest using immunoprecipitation before Western blotting

  • Use signal amplification systems

  • Consider more sensitive detection methods like Nano-ELISA

How does IKBKG phosphorylation at Ser376 influence the differential regulation of NF-κB versus MAPK pathways?

The phosphorylation of IKBKG at Ser376 appears to play a critical role in pathway bifurcation, where it differentially affects NF-κB and MAPK signaling branches. Research has revealed that this phosphorylation is particularly important for ERK phosphorylation and p65 nuclear translocation, while having less impact on p38 MAPK activation and IκBα degradation .

Experimental evidence suggests that IKBKG Ser376 phosphorylation may serve as a molecular switch that:

• Selectively regulates MAPK pathways: In cells with IKBKG L153P mutation (which affects function without preventing protein expression), p38 MAPK phosphorylation occurred normally while phosphorylation of p105, MEK, and ERK was severely impaired .

• Enables complete NF-κB activation: Despite preserved IκBα degradation in mutant cells, nuclear translocation of p65 was suppressed, with p65 accumulating in the cytoplasmic fraction instead . This indicates that Ser376 phosphorylation regulates post-IκBα degradation events essential for complete NF-κB activation.

• Coordinates pathway crosstalk: The differential impact on various signaling components suggests that Ser376 phosphorylation may serve as a coordination point for crosstalk between NF-κB and MAPK pathways, particularly affecting ERK-dependent processes.

This selective regulation highlights the mechanistic complexity beyond the traditional view that IKBKG function is primarily defined by enabling IκBα degradation.

What is the relationship between IKBKG Ser376 phosphorylation and immune dysregulation disorders?

IKBKG Ser376 phosphorylation has significant implications for immune regulation, as evidenced by research on IKBKG mutations:

• Selective immune deficiencies: Mutations affecting IKBKG function, including those potentially influencing Ser376 phosphorylation, can cause immune deficiencies without impairing other physiological processes. For example, the L153P mutation in mice impaired TLR signaling and conferred susceptibility to viral and bacterial infection, yet did not cause ectodermal dysplasia typically associated with complete IKBKG deficiency .

• Lymphoid tissue development: Phosphorylation status at Ser376 may influence lymphoid tissue formation, as hemizygous males with the L153P IKBKG mutation typically lacked inguinal lymph nodes .

• Adaptive immune cell development: IKBKG phosphorylation appears critical for proper development of memory, regulatory, and natural killer T cells, as these populations were reduced in mice with IKBKG mutations .

• Antibody production: Serum immunoglobulin concentrations were reduced in mice with IKBKG mutations, suggesting a role for proper IKBKG phosphorylation in B cell function and antibody production .

• Inflammatory balance: The selective impairment of ERK phosphorylation and p65 nuclear translocation while preserving p38 MAPK signaling suggests that altered IKBKG phosphorylation could dysregulate the balance between different inflammatory pathways, potentially contributing to immunopathology .

Understanding how Ser376 phosphorylation influences these processes could provide insights into immunodeficiency disorders and potentially identify novel therapeutic targets.

How can phospho-specific IKBKG antibodies be integrated into multi-parameter flow cytometry panels for immune cell signaling analysis?

Integrating phospho-specific IKBKG (Ser376) antibodies into multi-parameter flow cytometry requires careful panel design:

• Antibody selection:

  • Use PE-conjugated mouse anti-human IKKγ (pS376) clone N19-39 for direct detection

  • Ensure compatibility with other fluorochromes in your panel by checking excitation/emission spectra

  • Consider signal strength when assigning fluorochromes (place phospho-IKBKG on brighter fluorochromes like PE)

• Stimulation and fixation protocol:

  • Stimulate cells with appropriate ligands (LPS, cytokines) for optimal timepoints

  • Rapidly fix with formaldehyde (typically 1.5%) to preserve phosphorylation status

  • Permeabilize with methanol or specialized permeabilization buffers compatible with phospho-epitopes

• Panel design strategy:

  • Include lineage markers on channels with minimal spillover into the PE channel

  • Add complementary phospho-proteins (p-ERK, p-p38, p-p65) on compatible fluorochromes

  • Include total IKBKG antibody when possible for normalization

• Controls for phospho-flow:

  • Unstimulated controls for baseline phosphorylation

  • Phosphatase-treated negative controls

  • Single-color controls for compensation

  • Fluorescence-minus-one (FMO) controls to set gates

• Analysis approach:

  • Examine phospho-IKBKG in specific immune subsets identified by lineage markers

  • Use biaxial plots of phospho-IKBKG vs. other phospho-proteins to identify signaling relationships

  • Consider dimensionality reduction techniques (tSNE, UMAP) for high-parameter datasets

This approach enables single-cell analysis of IKBKG phosphorylation in heterogeneous populations, revealing cell type-specific signaling patterns that might be obscured in bulk analyses.